Janus Henderson Group’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.6M | Sell |
1,962,060
-237,573
| -11% | -$4.31M | 0.02% | 452 |
|
|
2025
Q1 | $47.9M | Buy |
2,199,633
+462,856
| +27% | +$10.1M | 0.03% | 383 |
|
|
2024
Q4 | $44.7M | Buy |
1,736,777
+196,048
| +13% | +$5.04M | 0.02% | 404 |
|
|
2024
Q3 | $25.6M | Buy |
1,540,729
+520,772
| +51% | +$8.66M | 0.01% | 525 |
|
|
2024
Q2 | $19.6M | Buy |
1,019,957
+383,726
| +60% | +$7.39M | 0.01% | 571 |
|
|
2024
Q1 | $15M | Buy |
+636,231
| New | +$15M | 0.01% | 612 |
|
|
2023
Q4 | – | Sell |
-434,912
| Closed | -$3.97M | – | 2587 |
|
|
2023
Q3 | $3.97M | Buy |
+434,912
| New | +$3.97M | ﹤0.01% | 887 |
|
|
2023
Q1 | – | Sell |
-563,119
| Closed | -$5.33M | – | 2708 |
|
|
2022
Q4 | $5.33M | Buy |
+563,119
| New | +$5.33M | ﹤0.01% | 847 |
|